Fabrication and Drug Delivery of Ultrathin Mesoporous Bioactive Glass Hollow Fibers

Ultrathin mesoporous bioactive glass hollow fibers (MBGHFs) fabricated using an electrospinning technique and combined with a phase-separaiion-induced agent, poly(ethylene oxide) (PEO), are described. The rapid solvent evaporation during electrospinning and the PEO-induced phase separation process demonstrated play vital roles in the formation of ultrathin bioactive glass fibers with hollow cores and mesoporous walls. Immersing the MBGHFs in simulated body fluid rapidly results in the development of a layer of enamel-like apatite mesocrystals at the fiber surfaces and apatite nanocrystals inside the hollow cores. Drug loading and release experiments indicate that the drug loading capacity and drug release behavior of the MBGHFs strongly depends on the fiber length. MBGHFs with fiber length >50 mu m can become excellent carriers for drug delivery. The shortening of the fiber length reduces drug loading amounts and accelerates drug release. The MBGHFs reported here with sophisticated structure, high bioactivity, and good drug delivery capability can be a promising scaffold for hard tissue repair and wound healing when organized into 3D macroporous membranes.

[1]  Haihua Pan,et al.  Roles of amorphous calcium phosphate and biological additives in the assembly of hydroxyapatite nanoparticles. , 2007, The journal of physical chemistry. B.

[2]  Heejoo Kim,et al.  Production and Potential of Bioactive Glass Nanofibers as a Next‐Generation Biomaterial , 2006 .

[3]  T. G. M. Ven,et al.  Dilute Aqueous Poly(ethylene oxide) Solutions: Clusters and Single Molecules in Thermodynamic Equilibrium , 1996 .

[4]  R. Fassihi,et al.  Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism. , 1997, Journal of pharmaceutical sciences.

[5]  Jianlin Shi,et al.  Hierarchically Porous Bioactive Glass Scaffolds Synthesized with a PUF and P123 Cotemplated Approach , 2007 .

[6]  D. Zhao,et al.  Mesoporous bioactive glasses. I. Synthesis and structural characterization , 2005 .

[7]  M. Vallet‐Regí,et al.  Glasses with Medical Applications , 2003 .

[8]  Xiabin Jing,et al.  Preparation, Bioactivity, and Drug Release of Hierarchical Nanoporous Bioactive Glass Ultrathin Fibers , 2010, Advanced materials.

[9]  Julian R Jones,et al.  Optimising bioactive glass scaffolds for bone tissue engineering. , 2006, Biomaterials.

[10]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[11]  Galen D. Stucky,et al.  Rapid‐Setting, Mesoporous, Bioactive Glass Cements that Induce Accelerated In Vitro Apatite Formation , 2006 .

[12]  Jiang Chang,et al.  Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[13]  P. Dayal,et al.  Porous Fiber Formation in Polymer-Solvent System Undergoing Solvent Evaporation , 2006 .

[14]  Jiang Chang,et al.  Fabrication and in vitro biomineralization of bioactive glass (BG) nanofibres , 2007, Nanotechnology.

[15]  T. Higuchi MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[16]  D. Pichora,et al.  Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release Properties , 1994, The Journal of pharmacy and pharmacology.

[17]  K. Nakanishi,et al.  Sol-gel with phase separation. Hierarchically porous materials optimized for high-performance liquid chromatography separations. , 2007, Accounts of chemical research.

[18]  G. Stucky,et al.  Spherical bioactive glass with enhanced rates of hydroxyapatite deposition and hemostatic activity. , 2006, Small.

[19]  E. Rinaki,et al.  The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. , 2003, International journal of pharmaceutics.

[20]  M. Vallet‐Regí,et al.  Synthesis Routes for Bioactive Sol−Gel Glasses: Alkoxides versus Nitrates , 2002 .

[21]  Julian R. Jones,et al.  Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. , 2007, Biomaterials.

[22]  M. Vallet‐Regí,et al.  Bioactivity of three CaO-P2O5-SiO2 sol-gel glasses. , 2002, Journal of biomedical materials research.

[23]  Panos Macheras,et al.  Fractal kinetics in drug release from finite fractal matrices , 2003 .

[24]  Xufeng Zhou,et al.  Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. , 2004, Angewandte Chemie.

[25]  Larry L. Hench,et al.  The story of Bioglass® , 2006, Journal of materials science. Materials in medicine.

[26]  D. Zhao,et al.  The in-vitro bioactivity of mesoporous bioactive glasses. , 2006, Biomaterials.

[27]  P. Dayal,et al.  Experimental and Theoretical Investigations of Porous Structure Formation in Electrospun Fibers , 2007 .

[28]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[29]  G. Stucky,et al.  Oxide hemostatic activity. , 2006, Journal of the American Chemical Society.